Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PVLA | HRMY | VCEL | ||
| Company | Palvella Therapeutics Inc | Harmony Biosciences Holdings Inc | Vericel Corporation | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 122.79 | 31.70 | 35.49 | ||
| High | 130.00 | 33.00 | 36.60 | ||
| Low | 117.79 | 31.70 | 35.22 | ||
| Latest | 127.61 | 32.59 | 36.49 | ||
| Change | +0.77 | +0.76 | +0.92 | ||
| % Change | +0.61% | +2.39% | +2.59% | ||
| Volume | 131,800 | 804,000 | 538,800 | ||
| 20-Day Average Volume | 200,630 | 872,385 | 522,350 | ||
| Previous Close | 126.84 | 31.83 | 35.57 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 127.15 | 30.33 | 34.79 | ||
| 20-Day Raw Stochastic | 57.26% | 68.91% | 75.76% | ||
| 20-Day Relative Strength | 53.69 | 62.15 | 55.45 | ||
| Weighted Alpha | +228.78 | -3.42 | -8.62 | ||
| Today's Opinion | 96% Buy | 8% Sell | 8% Buy | ||
| Previous Opinion | 96% Buy | 24% Sell | 24% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.80% since 04/27/26 | +4.96% since 04/27/26 | -1.16% since 04/27/26 | ||
| Low | 117.79 on 05/04/26 | 30.63 on 04/28/26 | 33.10 on 04/29/26 | ||
| High | 132.72 on 04/28/26 | 33.00 on 05/04/26 | 37.61 on 04/28/26 | ||
| 1-Month | |||||
| %Chg | +3.36% since 04/02/26 | +17.48% since 04/02/26 | +6.88% since 04/02/26 | ||
| Low | 112.83 on 04/07/26 | 27.27 on 04/07/26 | 32.99 on 04/13/26 | ||
| High | 138.64 on 04/22/26 | 34.99 on 04/21/26 | 37.61 on 04/28/26 | ||
| 3-Month | |||||
| %Chg | +55.60% since 02/04/26 | -12.67% since 02/04/26 | -1.06% since 02/04/26 | ||
| Low | 74.40 on 02/05/26 | 25.90 on 02/24/26 | 28.95 on 03/27/26 | ||
| High | 151.18 on 02/26/26 | 38.21 on 02/10/26 | 38.98 on 02/20/26 | ||
| 6-Month | |||||
| %Chg | +70.01% since 11/04/25 | +6.09% since 11/04/25 | +0.66% since 11/04/25 | ||
| Low | 72.22 on 11/05/25 | 25.90 on 02/24/26 | 28.95 on 03/27/26 | ||
| High | 151.18 on 02/26/26 | 40.87 on 12/15/25 | 43.00 on 11/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,815,588 | 1,841,907 | 1,811,651 | ||
| Shares Outstanding, K | 14,314 | 57,867 | 50,932 | ||
| Annual Sales | 0 | 868,450,000 | 276,260,000 | ||
| Annual Net Income | -41,720,000 | 158,690,000 | 16,520,000 | ||
| Last Quarter Sales | 0 | 243,780,000 | 92,920,000 | ||
| Last Quarter Net Income | -12,710,000 | 22,490,000 | 23,240,000 | ||
| 60-Month Beta | -0.13 | 0.97 | 1.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.08 on 03/31/26 | 0.38 on 02/24/26 | 0.45 on 02/26/26 | ||
| Earnings Date | 05/07/26 | 05/07/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.54 | 112.03 | ||